Thanks Brian - this is helpful context. Your statement about "high expectation from previous data/experience ... would work at least as well or the trial would not have been approved" is logical to me as well, but I was hoping as a patient to get a glimpse of what some of that specific data/experience to understand it for myself. I'm looking for more detail on the known success to date with all throat cancer patients with Erbitux, and why they think it may be even better for HPV.

I'm also wondering if insurance companies may have an issue covering Erbitux or related treatments from a "clinical study" that is not the current standard of care.